We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




One-Step Method Screens Pregnant Women for Streptococci B

By LabMedica International staff writers
Posted on 27 May 2010
A new one-step method that screens pregnant women for the presence of group B streptococci (GBS) produces positive results as early as 6 hours after inoculation. More...


The Strep B carrot broth kit, a unique modification of Granada broth, is used for the selective enrichment and identification of beta-hemolytic group B streptococci (Streptococcus agalactiae) from clinical specimens.

The production of orange, red, or brick red pigment is a unique characteristic of hemolytic GBS due to reaction with substrates such as starch, proteose peptone, serum, and folate pathway inhibitors. These components serve as the basis for culture media used to detect and identify these organisms.

A product of Hardy Diagnostics (Santa Maria, CA, USA), modification of the Granada broth (the separation of the supplements) increases the shelf life of the product and ensures well-defined and reliable pigment production in the presence of GBS. The advantage of this medium is that it is a single tube system that does not require subculturing to a blood agar plate, unless the results are negative.

Carrot broth was found to be more sensitive than the Lim broth and Granada agar plate methods, and even polymerase chain reaction (PCR). It is also reliable for the preservation of GBS should the physician request susceptibility testing at a later date.

A companion product for Strep B carrot broth assists in the isolation and identification of the nonhemolytic strains of GBS (which comprise 0.5% - 5.9% of the total GBS isolates.) The GBS Detect plate is used when subculturing the negative Strep B carrot broth cultures. It contains selective agents and hemolysis enhancers to cause nonhemolytic strains to appear hemolytic, so they can easily be recognized and identified within 24 hours.

Approximately 10-35% of women are asymptomatic carriers of group B streptococci (GBS) in the genital and gastrointestinal tracts. GBS remains a leading cause of serious illness and death in newborn populations, and therefore, the detection of GBS in the vaginal-anorectal area is critical to the prevention of neonatal GBS disease.

Related Links:
Hardy Diagnostics



Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Real-Time PCR System
Gentier 96T
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.